The ongoing debate about nodal radiotherapy in the post operative ER+ HER2- low nodal disease (1-2 SLN) - fairly close split in opinion still! #SGBCC2025

Key takeaway messages from Angela de Michele on which group of patients should warrant adjuvant CDK 4/6 inhibitors. Are we going to cure more patients? #SGBCC2025

Absolutely loved this talk by Dr Oliveira calling for nuanced discussions with patients re risk and benefit in the era of neoadjuvant immunotherapy in TNBC. Chronic toxicities and effect on quality of life not to be underestimated. #SGBCC2025

😑No benefit to addition of cisplatin to #radiotherapy in intermediate risk #cervicalcancer after surgery. 🤢 Adverse events higher in combo #SGOMtg #SGO2025 #gyncsm

What minimum TNBC size justifies adjuvant chemo? According to the #SGBCC2025 panel 👉5 mm

Optimal duration of endocrine treatment in different clinical situations:

ARCHIVED NASA Astronauts SpaceX What a sight! The parachutes on SpaceX's Dragon spacecraft have deployed; #Crew9 will shortly splash down off the coast of Florida near Tallahassee.

5 years out from chemo radiotherapy for locally advanced cervix cancer - yesterday, she gave me a big hug. She received her brachytherapy during the thick of COVID. These moments are why we do this. ☢️ saves lives. #thisisbrachytherapy #RadOnc

Big thanks to Caroline Tweedie for the powerful reminder of the benefits of exercise in cancer care - both for patients' recovery and physician well being! Here's Tom Tom Spencer putting his grip strength to the test!#Exerciseismedicine

⚡️🔥🚀 At #ESTRO2025, PORTEC-4a showed the value of molecular profiling in endometrial cancer: •~50% spared adjuvant Tx •Excellent local control •EBRT improves outcomes in high-risk profiles A big leap for personalized cancer care! #PORTEC4a #RadOnc #GyneOnc

Great vibes, great food, great people! #brachycrew

Opinions remain split on the role of induction chemotherapy in #cervixcancer. Is dose optimized RT and brachy just as good for most patients? #UKOF25

Radiotherapy is vital - but underfunded and overstretched. Used in 40-50% of all cancer patients Currently only 7% of all cancer spend Patients now face increasingly longer times for RT ☢️ is affordable and effective - we need to invest more in RT now. #nhs #cancercare

Me: Describes hypocalcaemia symptoms casually. Urologist husband: That's Chvostek's sign isn't it. Please. I did MRCP. Let me have this one! Rajan Veeratterapillay

🙌🏽

It’s September – Gynecologic Cancer Awareness Month! 💜 To honor this month, IGCS and IJGC are bringing you impactful educational opportunities all month long. Join us in raising awareness and advancing knowledge in gynecologic oncology. igcs.org/gynecologic-ca…

There are 5 Gynaecological (Gynae) cancers and knowing the possible symptoms as well as being confident to talk about them could be a lifesaver and challenge the stigma that prevents so many getting help. #GynaeCancerAwarenessMonth #GynaeCancers